1.Characteristics of Hemorrhagic Peptic Ulcers in Patients Receiving Antithrombotic/Nonsteroidal Antiinflammatory Drug Therapy.
Kazuhiko NAKAMURA ; Kazuya AKAHOSHI ; Toshiaki OCHIAI ; Keishi KOMORI ; Kazuhiro HARAGUCHI ; Munehiro TANAKA ; Norimoto NAKAMURA ; Yoshimasa TANAKA ; Kana KAKIGAO ; Haruei OGINO ; Eikichi IHARA ; Hirotada AKIHO ; Yasuaki MOTOMURA ; Teppei KABEMURA ; Naohiko HARADA ; Yoshiharu CHIJIIWA ; Tetsuhide ITO ; Ryoichi TAKAYANAGI
Gut and Liver 2012;6(4):423-426
BACKGROUND/AIMS: Antithrombotic/nonsteroidal antiinflammatory drug (NSAID) therapies increase the incidence of upper gastrointestinal bleeding. The features of hemorrhagic peptic ulcer disease in patients receiving antithrombotic/NSAID therapies were investigated. METHODS: We investigated the medical records of 485 consecutive patients who underwent esophagogastroduodenoscopy and were diagnosed with hemorrhagic gastroduodenal ulcers. The patients treated with antithrombotic agents/NSAIDs were categorized as the antithrombotic therapy (AT) group (n=213). The patients who were not treated with antithrombotics/NSAIDs were categorized as the control (C) group (n=263). The clinical characteristics were compared between the groups. RESULTS: The patients in the AT group were significantly older than those in the C group (p<0.0001). The hemoglobin levels before/without transfusion were significantly lower in the AT group (8.24+/-2.41 g/dL) than in the C group (9.44+/-2.95 g/dL) (p<0.0001). After adjusting for age, the difference in the hemoglobin levels between the two groups remained significant (p=0.0334). The transfusion rates were significantly higher in the AT group than in the C group (p=0.0002). However, the outcome of endoscopic hemostasis was similar in the AT and C groups. CONCLUSIONS: Patients with hemorrhagic peptic ulcers receiving antithrombotic/NSAID therapies were exposed to a greater risk of severe bleeding that required transfusion but were still treatable by endoscopy.
Anti-Inflammatory Agents, Non-Steroidal
;
Endoscopy
;
Endoscopy, Digestive System
;
Hemoglobins
;
Hemorrhage
;
Hemostasis, Endoscopic
;
Humans
;
Incidence
;
Medical Records
;
Peptic Ulcer
2.Association between Asian dust exposure and respiratory function in children with bronchial asthma in Nagasaki Prefecture, Japan.
Takahiro NAKAMURA ; Yuji NISHIWAKI ; Kunio HASHIMOTO ; Ayano TAKEUCHI ; Tasuku KITAJIMA ; Kazuhiro KOMORI ; Kasumi TASHIRO ; Hideki HASUNUMA ; Kayo UEDA ; Atsushi SHIMIZU ; Hiroshi ODAJIMA ; Hiroyuki MORIUCHI ; Masahiro HASHIZUME
Environmental Health and Preventive Medicine 2020;25(1):8-8
BACKGROUND:
Studies on the adverse effects of Asian dust (AD) on respiratory function in children are scarce. The objective of this study was to examine the association between AD and respiratory function by measuring peak expiratory flow rates (PEFRs) in asthmatic children.
METHODS:
The study was carried out from March to May from 2014 through 2016. One hundred ten children with bronchial asthma were recruited from four hospitals in the Goto Islands and south Nagasaki area in Nagasaki prefecture. The parents were asked to record their children's PEFRs every morning/evening and clinical symptoms in an asthma diary. AD was assessed from light detection and ranging data, and a linear mixed-effects model was used to estimate the effects of AD on daily PEFR. Time-stratified case-crossover analyses were performed to examine the association between AD and asthma attacks defined by reduction levels in PEFR.
RESULTS:
AD was detected on 11 days in the Goto Islands, and on 23 days in the south Nagasaki area. After adjusting for age, sex, temperature, and daily oxidants, we found a consistent association between AD and a 1.1% to 1.7% decrease in PEFR in the mornings and a 0.7% to 1.3% decrease in the evenings at a lag of 0 to 5 days. AD was not associated with the number of asthma attacks, respiratory symptoms, or other symptoms at any lag days examined.
CONCLUSIONS
Exposure to AD was associated with reduced PEFR, although the effects were not large enough to induce clinically apparent symptoms, in clinically well-controlled asthmatic children.